Complicaciones del tratamiento de la enfermedad de Parkinson. ¿Cómo manejamos la psicosis en la enfermedad de Parkinson?

García-Moreno, José Manuel.
Rev. neurol. (Ed. impr.) ; 50(supl.4): s51-s51, 29 mayo, 2010.
Artículo en Español | IBECS (España) | ID: ibc-86915

Documentos relacionados

  1. Treatment of refractory substance-induced psychosis in adolescent males with a genetic predisposition to mental illness.
  2. Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study.
  3. Long-term follow-up (24 months) of quetiapine treatment in drug-induced Parkinson disease psychosis.
  4. Tacrolimus-associated mania with psychotic symptoms in a child after renal transplant.
  5. Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.
  6. Prolonged Psychosis With Catatonia due to 2,5-Dimethoxy-4-Bromoamphetamine: Case Report and Literature Review.
  7. Treatment-Refractory Mania with Psychosis in a Post-Transplant Patient on Tacrolimus: A Case Report.
  8. Report of a case of steroid-induced psychosis and inappropriate sexual behaviour in an adolescent.
  9. Treatment for amphetamine psychosis.
  10. Treatment for amphetamine psychosis.